During his presentation at Personalised Medicines & Biomarkers 2015 Mohammad Afshar will share real-life examples of our KEM® platform application.
15:00 – Multi component biomarker signature for drug development and treatment selection
- Challenges developing Multi Analyte Algorithmic diagnostic Tests (MAAT)
- Illustration of the over fitting issue when number of samples is orders of magnitute smaller than the quantity of information for each sample.
- Real life examples: ExtempoNMR- real time metabolomic cancer diagnostics and onco KEM therapeutic decision support systems
MOHAMMAD AFSHAR, CEO, Ariana Pharma